Follow
Iain Macpherson
Iain Macpherson
Institute of Cancer Sciences, University of Glasgow
Verified email at glasgow.ac.uk
Title
Cited by
Cited by
Year
Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression
MA Dozynkiewicz, NB Jamieson, I MacPherson, J Grindlay, ...
Developmental cell 22 (1), 131-145, 2012
3122012
Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry
VG Brunton, IRJ MacPherson, MC Frame
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1692 (2-3), 121-144, 2004
2192004
N-WASP coordinates the delivery and F-actin–mediated capture of MT1-MMP at invasive pseudopods
X Yu, T Zech, L McDonald, EG Gonzalez, A Li, I Macpherson, JP Schwarz, ...
Journal of cell biology 199 (3), 527-544, 2012
1662012
Comparing breast cancer multiparameter tests in the OPTIMA prelim trial: no test is more equal than the others
J Bartlett, J Bayani, A Marshall, JA Dunn, A Campbell, C Cunningham, ...
JNCI: Journal of the National Cancer Institute 108 (9), 2016
1652016
Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors
GD Demetri, PL Russo, IRJ MacPherson, D Wang, JA Morgan, ...
Clinical Cancer Research 15 (19), 6232-6240, 2009
1542009
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
U Banerji, CML van Herpen, C Saura, F Thistlethwaite, S Lord, V Moreno, ...
The Lancet Oncology 20 (8), 1124-1135, 2019
1482019
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib
A Serrels, IRJ Macpherson, TRJ Evans, FY Lee, EA Clark, OJ Sansom, ...
Molecular cancer therapeutics 5 (12), 3014-3022, 2006
1372006
Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice
H Cain, IR Macpherson, M Beresford, SE Pinder, J Pong, JM Dixon
Clinical Oncology 29 (10), 642-652, 2017
962017
CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer
IR Macpherson, E Rainero, LE Mitchell, PVE van den Berghe, C Speirs, ...
Journal of cell science 127 (18), 3893-3901, 2014
942014
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
NC Turner, B Kingston, LS Kilburn, S Kernaghan, AM Wardley, ...
The Lancet Oncology 21 (10), 1296-1308, 2020
922020
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
D Novo, N Heath, L Mitchell, G Caligiuri, A MacFarlane, D Reijmer, ...
Nature communications 9 (1), 1-17, 2018
732018
p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism
IR Macpherson, S Hooper, A Serrels, L McGarry, BW Ozanne, ...
Oncogene 26 (36), 5214-5228, 2007
732007
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity
JR Hernandez-Fernaud, E Ruengeler, A Casazza, LJ Neilson, E Pulleine, ...
Nature communications 8 (1), 1-17, 2017
612017
Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells
E Dornier, N Rabas, L Mitchell, D Novo, S Dhayade, S Marco, G Mackay, ...
Nature communications 8 (1), 1-14, 2017
592017
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
L Rooshenas, LJ Scott, JM Blazeby, CA Rogers, KM Tilling, S Husbands, ...
Journal of clinical epidemiology 106, 108-120, 2019
492019
A phase I expansion cohorts study of SYD985 in heavily pretreated patients with HER2-positive or HER2-low metastatic breast cancer.
C Saura, F Thistlethwaite, U Banerji, S Lord, V Moreno, I MacPherson, ...
Journal of Clinical Oncology 36 (15_suppl), 1014-1014, 2018
492018
Current status of cediranib: the rapid development of a novel anti-angiogenic therapy
CR Lindsay, IRJ MacPherson, J Cassidy
Future Medicine Ltd 5 (4), 421-432, 2009
492009
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial
G Argilés, MP Saunders, F Rivera, A Sobrero, CG Ponce, S Cascinu, ...
European journal of cancer 51 (8), 942-949, 2015
412015
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …
J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...
European Journal of Cancer 82, 237-246, 2017
382017
Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial
PS Hall, A Smith, C Hulme, A Vargas-Palacios, A Makris, ...
Value in Health 20 (10), 1311-1318, 2017
322017
The system can't perform the operation now. Try again later.
Articles 1–20